Comorbidity-Guided Text Mining and Omics Pipeline to Identify Candidate Genes and Drugs for Alzheimer's Disease

Iyappan Ramalakshmi Oviya1, Divya Sankar2, Sharanya Manoharan3

  • 1Department of Computer Science and Engineering, Amrita School of Computing, Amrita Vishwa Vidyapeetham, Chennai 641112, India.

Genes
|May 25, 2024
PubMed

Insights

This study identifies common genes between Alzheimer's disease (AD) and comorbid conditions like dementia and diabetes. It suggests potential drugs like MG-132 for treating AD and related diseases.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Alzheimer's disease (AD) is a prevalent neurodegenerative disorder in the elderly, characterized by complex genetic factors.
  • Current AD treatments are limited, highlighting the need for novel therapeutic strategies.
  • Elderly patients often have multiple comorbid conditions, complicating treatment plans.

Purpose of the Study:

  • To identify diseases comorbid with Alzheimer's disease using text mining.
  • To pinpoint common genes shared between AD and five major comorbid diseases: dementia, type 2 diabetes, hypertension, Parkinson's disease, and Down syndrome.
  • To discover potential therapeutic drugs targeting these common genes for enhanced treatment strategies.

Main Methods:

  • A hybrid pipeline combining text mining and omics approaches was developed.
  • Text mining identified comorbid diseases associated with AD.
  • Omics analysis pinpointed common genes and pathways between AD and its comorbidities, followed by gene-drug interaction analysis using LINCS perturbation.

Main Results:

  • Seven common genes (PSEN1, PSEN2, MAPT, APP, APOE, NOTCH, HFE) were identified between AD and the five comorbid diseases.
  • Analysis revealed potential drug candidates, including MG-132 and Masitinib, targeting these common genes.
  • These identified drugs show promise for treating both AD and its comorbid conditions.

Conclusions:

  • The study successfully identified shared genetic factors and potential therapeutic targets for AD and its common comorbidities.
  • The proposed hybrid pipeline offers a novel approach for drug discovery in complex, multifactorial diseases.
  • The findings suggest that targeting common genes could lead to more effective, integrated treatment strategies for elderly patients with multiple conditions.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
465
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.3K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
180
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
36.3K